Method of screening candidate compounds for susceptibility to biliary excretion

Details for Australian Patent Application No. 2005250355 (hide)

Owner The University of North Carolina at Chapel Hill

Inventors Brouwer, Kim L.; Tian, Xianbin; Zhang, Peijin

Agent Griffith Hack

Pub. Number AU-B-2005250355

PCT Pub. Number WO2005/118787

Priority 10/842,404 10.05.04 US

Filing date 10 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 29 September 2011

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/118787 Priority application(s): WO2005/118787

29 September 2011 Application Accepted

  Published as AU-B-2005250355

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250356-Bicyclic heterocycles as HIV integrase inhibitors

2005250354-Multi-modal vinyl ester resins